Status:
RECRUITING
Pharmacist Guided Pre-emptive Pharmacogenetic Testing in Antidepressant Therapy
Lead Sponsor:
PD Dr. med. Thorsten Mikoteit
Collaborating Sponsors:
Psychiatrische Dienste Solothurn
Privatklinik Wyss
Conditions:
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study at the Solothurn Psychiatric Clinic, the investigators compare the effectiveness and tolerability of antidepressant pharmacotherapy in three groups. In the intervention group, the physic...
Eligibility Criteria
Inclusion
- ≥ 18 years old
- Diagnosis unipolar moderate or severe depressive episode or recurrent depressive disorder (ICD10: F32.1/32.2/33.1/33.2)
- HAM-D17 ≥ 17
Exclusion
- Acute suicide risk
- Psychotic symptomatology
- Other acute serious psychiatric disorder other than depression
- Excessive consumption of alcohol and/or drugs
- Severe acute - or severe chronic somatic diseases
- Pregnant / lactating women
- Under current treatment with fluoxetine
Key Trial Info
Start Date :
September 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT04507555
Start Date
September 15 2020
End Date
December 31 2025
Last Update
January 20 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Privatklinik Wyss
Münchenbuchsee, Canton of Bern, Switzerland, 3053
2
Psychiatrische Dienste Solothurn
Solothurn, Canton of Solothurn, Switzerland, 4503
3
Luzerner Psychiatrie AG
Sankt Urban, Switzerland, 4915
4
Psychiatrische Universitätsklinik Zürich
Zurich, Switzerland, 8032